TORONTO, Aug. 15 /CNW/ - Alegro Health Corp. (TSX-V: AGO), a provider of
medical, surgical and disability management services, today announced that
pursuant to terms and conditions of the Company's stock option plan, granted a
total of 600,000 stock options to Mr. Steven Goldman (100,000); Dr. Roger
Korman (100,000); Mr. Bob Leshchyshen (25,000); Dr. Robert MacMillan
(100,000); Mr. Michael O'Keefe (100,000); Dr. Kenneth Pritzker (100,000); Ms.
Brenda Rasmussen (25,000); Mr. Gilbert Sharpe (25,000); and Ms. Sandra D'Souza
(25,000) on July 9, 2008. The stock options were issued at an exercise price
of $0.275 and expire July 9, 2013.
Additionally, the Corporation also granted 500,000 stock options to Paul
Godard, Chief Financial Officer, on June 2, 2008 pursuant to the Corporation's
2003 Stock Option Plan. The stock options were issued at an exercise price of
$0.34 and expire June 2, 2013.
About Alegro Health Corp.
Alegro Health Corp. is a leading Canadian healthcare services provider
that offers medical and consulting services to corporations and individuals.
Through the company's subsidiaries - Don Mills Surgical Unit, Work Able
Centres, Direct Health Solutions and CanAm Research - Alegro provides a
variety of surgical procedures, disability management, third-party medical
assessments and support of drug trial administration. With a broad service
offering and the growth of the healthcare services sector, Alegro is pursuing
a vertically integrated approach and an aggressive acquisition strategy to
become Canada's leading third-party healthcare services provider. Alegro is
listed on the TSX Venture Exchange under the symbol AGO. For further
information, please visit www.alegrohealth.com.
Certain information in this press release is based on beliefs and
assumptions of the Company's senior management and information currently
available to it that may constitute forward-looking information within the
meaning of securities laws. Such statements reflect the current views of the
Company with respect to future events and are subject to certain risks and
uncertainties. Actual results, events, and performance may differ materially.
Readers are cautioned not to place undue reliance on these forward-looking
This release was prepared by management of the Company who takes full
responsibility for its contents. The TSX Venture Exchange has not
reviewed and does not accept responsibility for the adequacy or accuracy
of this news release.
For further information:
For further information: Brenda Rasmussen, President and CEO, (416)
496-6166 x-328, email@example.com; Michael Moore, Investor
Relations, (416) 815-0700 x241, firstname.lastname@example.org